This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silva, A. J.
Right arrow Articles by Benitez, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silva, A. J.
Right arrow Articles by Benitez, J. A.

 Previous Article  |  Next Article 

Journal of Bacteriology, November 2008, p. 7335-7345, Vol. 190, No. 22
0021-9193/08/$08.00+0     doi:10.1128/JB.00360-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Role of the Histone-Like Nucleoid Structuring Protein in the Regulation of rpoS and RpoS-Dependent Genes in Vibrio cholerae{triangledown} ,{dagger}

Anisia J. Silva,1* Syed Zafar Sultan,1 Weili Liang,2 and Jorge A. Benitez1

Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, 720 Westview Dr., SW, Atlanta, Georgia 30310,1 State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changping, Beijing 102206, China2

Received 11 March 2008/ Accepted 27 August 2008


arrow
ABSTRACT
 
Production of the Zn-metalloprotease hemagglutinin (HA)/protease by Vibrio cholerae has been reported to enhance enterotoxicity in rabbit ileal loops and the reactogenicity of live cholera vaccine candidates. Expression of HA/protease requires the alternate sigma factor {sigma}S (RpoS), encoded by rpoS. The histone-like nucleoid structuring protein (H-NS) has been shown to repress rpoS expression in Escherichia coli. In V. cholerae strains of the classical biotype, H-NS has been reported to silence virulence gene expression. In this study we examined the role of H-NS in the expression of HA/protease and motility in an El Tor biotype strain by constructing a {Delta}hns mutant. The {Delta}hns mutant exhibited multiple phenotypes, such as production of cholera toxin in nonpermissive LB medium, reduced resistance to high osmolarity, enhanced resistance to low pH and hydrogen peroxide, and reduced motility. Depletion of H-NS by overexpression of a dominant-negative allele or by deletion of hns resulted in diminished expression of HA/protease. Epistasis analysis of HA/protease expression in {Delta}hns, {Delta}rpoS, and {Delta}hns {Delta}rpoS mutants, analysis of RpoS reporter fusions, quantitative reverse transcription-PCR measurements, and ectopic expression of RpoS in {Delta}rpoS and {Delta}rpoS {Delta}hns mutants showed that H-NS posttranscriptionally enhances RpoS expression. The {Delta}hns mutant exhibited a lower degree of motility and lower levels of expression of flaA, flaC, cheR-2, and motX mRNAs than the wild type. Comparison of the mRNA abundances of these genes in wild-type, {Delta}hns, {Delta}rpoS, and {Delta}hns {Delta}rpoS strains revealed that deletion of rpoS had a more severe negative effect on their expression. Interestingly, deletion of hns in the rpoS background resulted in higher expression levels of flaA, flaC, and motX, suggesting that H-NS represses the expression of these genes in the absence of {sigma}S. Finally, we show that the cyclic AMP receptor protein and H-NS act along the same pathway to positively affect RpoS expression.


arrow
INTRODUCTION
 
Cholera is an acute diarrheal disease characterized by the passing of voluminous rice water stool. Vibrio cholerae of serogroups O1 and O139 continues to cause seasonal cholera outbreaks that affect highly populated regions in Asia, Africa, and Latin America. The bacterium can persist outside the human host and alternates between planktonic and biofilm community lifestyles. V. cholerae is a highly motile organism with a single sheathed polar flagellum. It colonizes the small intestine and expresses a variety of virulence determinants, such as the toxin-coregulated pilus (TCP) and cholera toxin (CT), encoded by tcpA (major subunit) and ctxA, respectively (13, 27). V. cholerae also secretes a Zn-dependent metalloprotease that displays a broad range of potentially pathogenic activities: hemagglutinin/protease (HA/protease), encoded by hapA (14, 18, 34, 59-61). HA/protease contributes to the reactogenicity of live cholera vaccine candidates and enhances enterotoxicity in the rabbit ileal loop model (4, 15, 51). Transcription of hapA requires the quorum-sensing regulator HapR (25), the cyclic AMP receptor protein (CRP) (3, 49, 31), and the alternative sigma factor S (RpoS), encoded by rpoS (49, 62).

The histone-like nucleoid structuring protein (H-NS), a global regulator of environmentally controlled gene expression, belongs to a family of small nucleoid-associated proteins that also include its paralog StpA, Fis, the heat-unstable protein (HU), and integration host factor (IHF) (13). Mutations that inactivate hns are highly pleiotropic, suggesting that H-NS influences a broad spectrum of physiological processes (1, 21). Escherichia coli H-NS (137 amino acids) consists of an N-terminal domain extending to residue 65 with oligomerization activity, connected by a flexible linker to a nucleic acid binding domain beginning at residue 90, whereas V. cholerae H-NS contains an additional oligomerization domain located within the first 24 amino acids of the protein's N terminus (1, 12, 44). Both oligomerization and DNA binding are required for the biological activity of H-NS (54). It has been suggested that H-NS functions primarily as a transcriptional repressor by binding to highly curved AT-rich DNA regions (46, 57).

Depletion of H-NS in V. cholerae of the classical biotype (by overexpression of a truncated hns allele lacking the DNA binding domain) induced pleiotropic effects such as the formation of mucoid colonies and reduced swarming in semisolid agar (56). Furthermore, V. cholerae hns mutants have been reported to exhibit diminished bile- and anaerobiosis-mediated repression of ctxA expression, motility, and intestinal colonization capacity (16, 30). H-NS has been shown to silence virulence gene expression by repressing transcription at different levels of the ToxR regulatory cascade, which include the toxT, tcpA, and ctxA promoters (45). At the level of the ctxA and tcpA promoters, the positive regulator ToxT binds to these promoters, displacing H-NS and allowing RNA polymerase (RNAP) to initiate transcription (63).

In E. coli, RpoS regulates the expression of more than 100 genes in response to starvation and other stresses such as osmotic shock, oxidative stress, and temperature (19). The intracellular concentration of {sigma}S is controlled at the levels of transcription, translation, and protein stability (19, 43, 58). At the level of transcription, the cyclic AMP-CRP complex has been shown to modulate the activity of an rpoS-lacZ transcriptional fusion by binding to CRP boxes in the rpoS promoter (19). Also, polyphosphate and guanosine tetraphosphate (ppGpp) have been shown to enhance rpoS transcription (19). At the level of translation, several trans-acting factors can bind to rpoS mRNA in response to high osmolarity, low temperature, and an acidic pH to enhance its translation (19). These factors include the RNA binding protein Hfq, the nucleoid-associated protein HU, and the small RNAs DsrA and RprA (19, 32). In addition, two riboregulators, OxyS and DsrA, enhance and diminish rpoS translation, respectively (19, 43, 58). At the protein level, the response regulator RssB is required for the degradation of {sigma}S by the housekeeping protease ClpXP (2, 19, 43, 58). H-NS has been shown to participate as a negative factor in the expression of RpoS by promoting rpoS mRNA degradation (6) and increasing the activity of RssB to enhance the proteolysis of {sigma}S (64).

V. cholerae rpoS mutants are more sensitive to starvation, high osmolarity, and oxidative stress than the wild type (62), suggesting an analogy to the role of RpoS in E. coli. However, very little is known about the regulation of RpoS expression in V. cholerae. Recently, it has been shown that multiple motility and chemotaxis genes are downregulated in an rpoS mutant, suggesting that RpoS could facilitate mucosal escape during infection by enhancing motility (42). Furthermore, V. cholerae rpoS mutants are affected in intestinal colonization (39), suggesting that RpoS could contribute to the ability of vibrios to overcome host-specific stresses in the gut. Since both H-NS and RpoS have been shown to affect cholera pathogenesis, we decided to examine the interaction between these global regulators. In this study we show that H-NS exerts positive regulation over RpoS and multiple RpoS-dependent genes, including hapA. Furthermore, we provide evidence that H-NS can affect the expression of some motility and chemotaxis genes through distinct and overlapping effects: (i) as a positive factor by posttranscriptionally enhancing RpoS expression and (ii) as a repressor or negative factor in the absence of {sigma}S. Finally, we show that CRP and H-NS act on the same pathway to enhance the expression of RpoS.


arrow
MATERIALS AND METHODS
 
Strains and media. The V. cholerae and E. coli strains used in this study are shown in Table 1. For CT production, V. cholerae strains were grown in AKI (23) and LB media at 30°C. For HA/protease production, vibrios were grown in Bacto tryptic soy broth (TSB) at 37°C with shaking (250 rpm). For motility determination, strains were stabbed into LB medium containing 0.3% agar (swarm agar) and incubated at 30°C for 16 h. Plasmid DNA was introduced into V. cholerae by electroporation (33). Culture media were supplemented with ampicillin (Amp; 100 µg/ml), kanamycin (Km; 50 µg/ml), 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal; 20 µg/ml), isopropyl-β-D-thiogalactopyranoside (IPTG; 20 µg/ml), or polymyxin B (PolB; 100 U/ml) as required.


View this table:
[in this window]
[in a new window]

 
TABLE 1. Strains and plasmids

Construction of mutants. Deletion mutants were constructed by allelic exchange using strain C7258 as a wild-type precursor. V. cholerae target sequences were amplified from genomic DNA of strain C7258 by using the Advantage PCR system (BD Biosciences Clontech). All primers (Table 2) were designed based on the DNA sequence of the V. cholerae N16961 genome, downloaded from the TIGR database (http://cmr.tigr.org). Amplification products were directionally cloned into pUC19 using E. coli TOP10 as the host and were confirmed by sequencing of both DNA strands with M13 forward and reverse primers. In all cases, mutants were obtained by cloning a chromosomal DNA fragment containing a deletion of the target gene in pCVD442 (11). The resulting suicide vectors were constructed in E. coli S17-1{lambda}pir (9) and mobilized into the corresponding V. cholerae receptor strain by conjugation. Exconjugants were selected on LB agar containing PolB, Amp, or Km as required. Next, sucrose selection was used to isolate segregants retaining the mutant allele. Using this approach, strain C7258 and the isogenic mutants AJB50 (C7258 {Delta}rpoS), AJB51 (C7258 {Delta}hapR), and WL7258 (C7258 {Delta}crp), described previously (31), were modified by deletion of the chromosomal lacZ gene. The corresponding lacZ deletion mutants (Table 1) were confirmed by DNA sequencing. A similar strategy was followed to construct the hns deletion/insertion ({Delta}hns::Km) mutant AJB80 (Table 1) starting from C7258{Delta}lacZ. Strain AJB80, containing the {Delta}hns::Km allele, was confirmed by Southern blotting and sequencing of the V. cholerae chromosome-Km junctions. Strains AJB81 ({Delta}lacZ {Delta}hns::Km {Delta}rpoS) and AJB82 ({Delta}lacZ {Delta}hns::Km {Delta}crp) (Table 1) were similarly obtained from AJB80 by allelic exchange using the suicide vectors pCVD{Delta}RpoS2 and pCVD{Delta}CRP (31), respectively. Again, mutants were confirmed by DNA sequencing. A detailed description of the strain construction procedures is provided as supplemental material.


View this table:
[in this window]
[in a new window]

 
TABLE 2. Primers

Plasmid constructions. The complete hns open reading frame (ORF) was amplified from strain C7258 and cloned into pUC19 to yield plasmid pHNS (Table 1). A truncated hns allele (hns90) was amplified from C7258 to generate a DNA fragment encoding the first 90 amino acids of H-NS. The truncated allele was cloned into plasmid pTTQ18 (55) to create the expression vector pTTHNS90 (Table 1), expressing hns90 from the Tac promoter. Similarly, the complete rpoS ORF was amplified and cloned into pTTQ18 to yield the expression vector pTTRpoS (Table 1). The RpoS reporter plasmid pPerA-LacZ (Table 1) was constructed by cloning the perA promoter region downstream of the rrnB T1T2 transcription terminator into pTT3 (Table 1) and subsequently subcloning the terminator-promoter fragment upstream of a promoterless lacZ gene into plasmid pKRZ1 (48). An identical strategy was used to construct a HapR reporter plasmid. In this case, we used the lux promoter amplified from cosmid pBB1 containing the Vibrio harveyi lux operon (41) to generate plasmid pLux-LacZ (Table 1). The construction of the rpoS-lacZ promoter fusion pRpoSLac5 (Table 1) has been described previously (49).

RT-PCR. V. cholerae strains were grown as described in each figure legend, and total RNA was isolated using the RNeasy kit (Qiagen Laboratories). The RNA samples were analyzed by quantitative real-time reverse transcription-PCR (qRT-PCR) using the iScript two-step RT-PCR kit with Sybr green (Bio-Rad Laboratories) as described previously (31). Relative expression values (R) were calculated as 2–({Delta}Ct target {Delta}Ct reference) where Ct is the fractional threshold cycle. recA mRNA was used as a reference. The following primer combinations were used: Bfr146 and Bfr431 for bfr mRNA, CheR377 and CheR587 for cheR-2 mRNA, Cyt835 and Cyt948 for c551 mRNA, FlaA40 and FlaA291 for flaA mRNA, FlaC405 and FlaC592 for flaC mRNA, KatB594 and KatB792 for katB mRNA, MotX253 and MotX374 for motX mRNA, PerA607 and PerA863 for perA mRNA, RecA578 and RecA863 for recA mRNA, RpoS576 and RpoS1003 for rpoS mRNA, and ToxR369 and ToxR498 for toxR mRNA. A control mixture lacking reverse transcriptase was run for each reaction to exclude chromosomal DNA contamination.

To assess the longevity of rpoS mRNA in the wild-type and {Delta}hns::Km mutant backgrounds, the strains were grown to an optical density at 600 nm (OD600) of 1.5, and rifampin was added (150 µg/ml) to block transcription. Samples were taken at different time points after the addition of rifampin, and rpoS mRNA was detected using the Titanium One-Step RT-PCR kit by following the manufacturer's instructions, with 20 {eta}g of total RNA and 25 cycles of amplification. Since less rpoS mRNA is produced in the {Delta}hns::Km mutant than in the wild type (see below), two additional cycles were provided for the mutant to generate a stronger starting signal.

Stress response assays. V. cholerae strains were grown for 18 h (to stationary phase) in LB medium at 37°C. The cells were centrifuged, washed, and resuspended in 1 volume of LB medium. The bacterial suspension was then inoculated into fresh LB medium that either contained 2.4 M NaCl or 3 mM hydrogen peroxide or was brought to pH 4.5 so as to obtain a cell density of 106 to 107 cells per ml. Cultures were incubated at 37°C with shaking (250 rpm), and samples were taken at different time points for dilution plating.

Determination of CT levels. CT levels were determined by a GM1 enzyme-linked immunosorbent assay using a standard curve of pure CT (Sigma Chemical Co.) as described previously (31).

Enzyme assays. Production of HA/protease was measured using an azocasein assay as described previously (3). One azocasein unit is the amount of enzyme that produces an increase of 0.01 OD unit in this assay. β-Galactosidase activity was measured as described previously (40) using the substrate o-nitrophenyl-β-D-galactopyranoside (ONPG). Specific activities are given in Miller units and calculated as [1,000 (OD420/t x v x OD600)] where t is the reaction time and v is the volume of enzyme extract per reaction.


arrow
RESULTS
 
Construction of a V. cholerae El Tor biotype hns deletion/insertion mutant. We have constructed an hns deletion/insertion mutant ({Delta}hns::Km) of the El Tor biotype strain C7258{Delta}lacZ. The mutant was confirmed by Southern blot analysis and DNA sequencing. Since it has been reported that H-NS negatively influences virulence gene expression in classical biotype V. cholerae, we first determined whether or not H-NS had a similar effect in the El Tor biotype mutant. The El Tor biotype {Delta}hns::Km mutant AJB80 produced 15.7 mg/liter/OD600 unit of CT in AKI cultures, compared to 2.6 mg/liter/OD600 unit produced by its wild-type precursor (C7258{Delta}lacZ) under identical conditions. Furthermore, while the wild-type strain did not produce detectable CT in nonpermissive LB medium, the {Delta}hns::Km mutant produced 3.8 mg/liter/OD600 unit of CT in LB medium. Moreover, in contrast to its wild-type precursor, the {Delta}hns::Km mutant expressed significant autoagglutination, an indicator of TCP expression (8), in LB medium (data not shown). These phenotypes were complemented by providing the hns gene in trans using plasmid pHNS. The results discussed above suggest that, as documented for hns mutants of the classical biotype (45), H-NS acts to silence virulence gene expression in the El Tor biotype. In addition, the {Delta}hns::Km mutant exhibited additional phenotypes typical of hns mutants, such as reduced growth rate and motility (see below).

H-NS acts upstream of RpoS to positively regulate the production of HA/protease. We have shown that transcription of hapA occurs in the stationary phase and requires RpoS (49). Since in E. coli H-NS has been reported to repress the expression of multiple RpoS-dependent genes (19, 20), we examined the role of H-NS in HA/protease expression. It has been reported that overexpression of a truncated hns allele lacking the DNA-binding domain leads to phenotypes reminiscent of those observed for hns mutants (56). Thus, we first examined if depletion of H-NS by overexpression of the truncated allele hns90 affected the production of HA/protease. As shown in Fig. 1A, induction of hns90 with IPTG had a strong negative effect on HA/protease expression relative to that by an uninduced control. In agreement with this result, elimination of hns by mutation in strain AJB80 ({Delta}hns::Km) strongly diminished the production of HA/protease (Fig. 1B). This phenotype was complemented by providing the wild-type hns allele in trans (Fig. 1B). As shown in Fig. 1B, deletion of rpoS had a more severe effect on HA/protease production (P < 0.05 by the t test). In order to examine the relationship between H-NS and RpoS in the regulation of HA/protease production, we constructed the {Delta}hns::Km {Delta}rpoS double mutant AJB81 and performed an epistasis analysis. Production of HA/protease by the {Delta}hns::Km {Delta}rpoS double mutant was similar to that by the {Delta}rpoS mutant, indicating that RpoS acts downstream of H-NS to activate HA/protease production (Fig. 1B). In Fig. 1C, we show that ectopic expression of H-NS in wild-type V. cholerae results in increased HA/protease production (P < 0.05 by the t test). Consistent with our epistasis analysis, overexpression of H-NS did not restore HA/protease expression in a {Delta}rpoS background. Taken together, we conclude that H-NS positively affects HA/protease expression by acting upstream of RpoS.


Figure 1
View larger version (20K):
[in this window]
[in a new window]

 
FIG. 1. Role of H-NS in HA/protease production. (A) Strain C7258{Delta}lacZ (wild type [WT]) containing pTTHNS90 was grown in TSB to an OD600 of 1, and the culture was divided in half. One half was induced by addition of IPTG, and the second half was used as a control. Cultures were further incubated for 3 h. (B) Strains C7258{Delta}lacZ (WT), AJB80 (C7258{Delta}lacZ {Delta}hns::Km), AJB50{Delta}lacZ ({Delta}rpoS), and AJB81 ({Delta}lacZ {Delta}hns::Km {Delta}rpoS) were grown to stationary phase (16 h) in TSB at 37°C. (C) Strain C7258{Delta}lacZ (WT) and strains C7258{Delta}lacZ and AJB50{Delta}lacZ ({Delta}rpoS) containing plasmid pHNS were grown as described above. Production of HA/protease (expressed in azocasein units) was measured as described in Materials and Methods. Each value is the average for three independent cultures. Error bars, standard deviations.

Since production of HA/protease requires both RpoS and the quorum-sensing regulator HapR, we examined if expression of these regulators was diminished in the {Delta}hns::Km mutant AJB80. For HapR expression, we constructed the reporter plasmid pLux-LacZ (Table 1). Expression of β-galactosidase from the lux promoter is dependent on the production of active HapR protein. As shown in Fig. 2A, the {Delta}hns::Km mutant produced a level of β-galactosidase activity similar to that of the wild type, while an isogenic {Delta}hapR mutant (AJB51{Delta}lacZ), used as a negative control, produced very little activity.


Figure 2
View larger version (29K):
[in this window]
[in a new window]

 
FIG. 2. Expression of HapR and RpoS reporter lacZ fusions in V. cholerae hns mutants. (A) Strains C7258{Delta}lacZ (wild type [WT]), AJB80 (C7258{Delta}lacZ {Delta}hns::Km), and AJB51{Delta}lacZ ({Delta}hapR) containing plasmid pLux-LacZ were grown to stationary phase (16 h) in TSB at 37°C. (B) Strains C7258{Delta}lacZ (WT), AJB80 (C7258{Delta}lacZ {Delta}hns::Km), and AJB50{Delta}lacZ ({Delta}rpoS) containing plasmid pPerA-LacZ were grown as described above. (C) Strains C7258{Delta}lacZ (WT) and AJB80 (C7258{Delta}lacZ {Delta}hns::Km) containing an rpoS-lacZ transcriptional fusion were grown as described above. β-Galactosidase activity was determined as described in Materials and Methods. Each value is the average for three independent cultures. Error bars, standard deviations.

Preliminary gene expression profiling of a {Delta}rpoS mutant of strain C7258 revealed that the VC1560 gene, annotated as catalase-peroxidase (perA), and VC0365 (bacterioferritin; bfr) were strongly downregulated in the {Delta}rpoS mutant (data not shown). Using the same strategy as that for the HapR reporter plasmid, we constructed a reporter plasmid (pPerA-LacZ) containing a perA-lacZ transcriptional fusion to monitor the production of active RpoS protein. As shown in Fig. 2B, significantly less RpoS activity was detected in the {Delta}hns::Km mutant than in the wild type, while negligible activity was observed in an isogenic {Delta}rpoS mutant used as a negative control. These results indicate that the lower production of HA/protease by the {Delta}hns::Km mutant is due to diminished expression of active RpoS protein.

Positive regulation of RpoS by H-NS is posttranscriptional. To determine if the lower expression level of RpoS in the {Delta}hns::Km mutant (Fig. 2B) was due to reduced transcription, we introduced the rpoS-lacZ transcriptional fusion pRpoSLac5 (49) into the wild-type and {Delta}hns::Km mutant strains. As shown in Fig. 2C, the two strains produced similar β-galactosidase activities, suggesting that H-NS affects RpoS expression by a posttranscriptional mechanism. In E. coli, H-NS has been reported to affect rpoS expression at the levels of translation and protein stability (19, 64). Therefore, we used qRT-PCR to measure the abundances of rpoS mRNA and the RpoS-dependent genes perA and bfr in C7258{Delta}lacZ and the {Delta}hns::Km mutant. As shown in Fig. 3, the {Delta}hns::Km mutant produced a smaller amount of rpoS mRNA than the wild type, and this was reflected in diminished expression of the RpoS-dependent genes perA and bfr. These results suggest that H-NS has a strong positive effect on rpoS mRNA translation/stability. To further test the hypothesis that H-NS regulates rpoS expression posttranscriptionally, we constructed the pTTRpoS vector (Table 1), which expresses RpoS from the Tac promoter. In Fig. 4 we show that IPTG-induction of pTTRpoS in strain AJB50lacZ ({Delta}rpoS) complemented the RpoS defect, leading to HA/protease production. However, significantly less HA/protease could be detected upon induction of pTTRpoS in strain AJB81 ({Delta}hns::Km {Delta}rpoS). Taken together, our data suggest that in contrast to E. coli, in V. cholerae H-NS posttranscriptionally enhances the expression of RpoS and multiple RpoS-dependent genes, such as hapA, perA, and bfr. We further examined the stability of rpoS mRNA in the wild-type and {Delta}hns::Km mutant strains. As shown in Fig. 5, and consistent with a posttranscriptional regulatory mechanism, the rpoS mRNA signal was found to disappear more rapidly in the {Delta}hns::Km mutant than in the wild-type after transcription had been blocked with rifampin.


Figure 3
View larger version (27K):
[in this window]
[in a new window]

 
FIG. 3. qRT-PCR analysis of rpoS expression in an hns mutant. Strains C7258{Delta}lacZ (wild type [WT]), AJB80 (C7258{Delta}lacZ {Delta}hns::Km), and AJB50{Delta}lacZ ({Delta}rpoS) were grown to stationary phase (16 h) in TSB at 37°C. RNA was extracted, and rpoS, perA, and bfr mRNA abundances were determined by qRT-PCR as described in Materials and Methods. Results are averages for three independent cultures. Error bars, standard deviations.


Figure 4
View larger version (26K):
[in this window]
[in a new window]

 
FIG. 4. Production of HA/protease as an indicator of ectopic expression of RpoS in {Delta}rpoS and {Delta}rpoS {Delta}hns mutants. Strains AJB50{Delta}lacZ ({Delta}rpoS) and AJB81 ({Delta}hns::Km {Delta}rpoS) containing plasmid pTTRpoS were grown in TSB medium to an OD600 of 1.0 and divided in half. One half was induced by the addition of IPTG, and the other half (uninduced) was used as a control. Samples were taken at different times to determine the production of HA/protease by using the azocasein assay described in Materials and Methods. Each data point is the mean for three independent cultures. Error bars, standard deviations.


Figure 5
View larger version (55K):
[in this window]
[in a new window]

 
FIG. 5. Analysis of rpoS mRNA longevity in a V. cholerae {Delta}hns mutant. Strains C7258{Delta}lacZ (wild type [WT]) and AJB80 (C7258{Delta}lacZ {Delta}hns::Km) were grown to an OD600 of 1.5 at 37°C; rifampin was added to block transcription; and samples were collected at different time points for RNA extraction and rpoS mRNA analysis as described in Materials and Methods.

H-NS affects the V. cholerae stress response. In V. cholerae, RpoS has been shown to mediate a general stress response (62). The results described above prompted us to investigate the role of H-NS in the V. cholerae response to environmental stressors. The {Delta}hns::Km and {Delta}rpoS mutants were both more sensitive to 2.4 M NaCl than the wild type (Fig. 6). This result is in agreement with the lower expression of RpoS in the {Delta}hns::Km mutant. However, the {Delta}hns::Km mutant was more resistant than the wild-type strain and the {Delta}rpoS mutant to 3 mM hydrogen peroxide (Fig. 6). In order to explain this result, we used qRT-PCR to determine the relative expression of other catalase/peroxidase genes present in the V. cholerae genome. We observed that the {Delta}hns::Km mutant expressed higher levels of VC0089, encoding c551 cytochrome/peroxidase, than the wild type (0.64 for the wild type and 4.7 for the {Delta}hns::Km mutant). In addition, elevated expression of VC1585, encoding KatB catalase, was observed in the {Delta}hns::Km mutant (levels were 0.030 for the wild type and 0.3 for the {Delta}hns::Km mutant). These results suggest that H-NS is a repressor of c551 and katB. Elevated expression of c551 and katB in the {Delta}hns::Km mutant explains its resistance to hydrogen peroxide in spite of expressing lower levels of the RpoS-dependent perA gene. The {Delta}hns::Km mutant also exhibited greater resistance than the wild type to a pH of 4.5 (Fig. 6). We have not observed elevated expression of lysine decarboxylase, known to mediate the inorganic acid tolerance response (36-38), in the {Delta}hns::Km mutant. However, we did observe that the {Delta}hns::Km mutant expressed higher toxR mRNA levels than the wild type and the {Delta}rpoS mutant (toxR mRNA levels were 0.31 for the wild type, 0.25 for the {Delta}rpoS mutant, and 0.64 for the {Delta}hns::Km mutant). Expression of ToxR has been reported to enhance resistance to organic acid shock (35).


Figure 6
View larger version (14K):
[in this window]
[in a new window]

 
FIG. 6. Responses of a V. cholerae El Tor biotype hns mutant to environmental stresses. V. cholerae strains were grown and prepared as described in Materials and Methods. They were then subjected to either 2.4 M NaCl, 3 mM hydrogen peroxide, or a pH of 4.5 in LB medium. At different time points, samples were withdrawn and the viable count determined by dilution plating. Each point is the average for three experiments. WT, wild type.

Role of H-NS in the expression of motility and chemotaxis. Gene expression profiling of V. cholerae C7258{Delta}rpoS revealed that several motility and chemotaxis genes were downregulated in the mutant background (data not shown). We found that both {Delta}rpoS and {Delta}hns::Km mutants were less motile than the wild type by using a swarm assay in semisolid agar medium (Fig. 7A). These results prompted us to examine the relationship between H-NS and RpoS in the regulation of motility and chemotaxis gene expression. To investigate the reduced motility of the {Delta}hns::Km mutant, we used qRT-PCR to measure the relative expression levels of the regulator genes flrA, flrB, flrC, fliA, and rpoN; the flagellin structural genes flaA and flaC; the motor genes motX and motY; and the chemotaxis genes cheA-2 (VC2063), cheR-2 (VC2201), and cheY-3 (VC2065). Inactivation of these genes, except flaC, impairs the ability of V. cholerae to swarm away from the inoculation site in semisolid agar (5, 17, 22, 47, 51). The {Delta}hns::Km mutant expressed lower flaA, flaC, motX, and cheR-2 mRNA levels than the wild type (Fig. 7B). Compared to the deletion of rpoS, the deletion of hns had a smaller but still very significant negative effect on the expression of these genes. cheR-2 was found to be the most strongly RpoS dependent gene under the experimental conditions used. An interesting pattern was observed for flaA, flaC, and motX expression in the {Delta}rpoS {Delta}hns double mutant. Although expression of these genes was lower in the {Delta}rpoS and {Delta}hns::Km single mutants than in the wild type, deletion of hns in the {Delta}rpoS background significantly enhanced their expression (t tests for flaA, flaC, and motX expression yielded P values of <0.05) (Fig. 7B).


Figure 7
View larger version (38K):
[in this window]
[in a new window]

 
FIG. 7. Role of H-NS in the expression of motility and chemotaxis. (A) Strains C7258{Delta}lacZ (wild type [WT]) and isogenic mutants AJB80 (C7258{Delta}lacZ {Delta}hns::Km), AJB50{Delta}lacZ ({Delta}rpoS), and AJB81 ({Delta}hns::Km {Delta}rpoS) were stabbed into LB medium containing 0.3% agar and incubated for 8 h at 30°C. (B) Strains C7258{Delta}lacZ (WT), AJB80 (C7258{Delta}lacZ {Delta}hns::Km), AJB50{Delta}lacZ ({Delta}rpoS), and AJB81 ({Delta}lacZ {Delta}hns::Km {Delta}rpoS) were grown in LB medium to an OD600 of 1.5 at 37°C. RNA was extracted, and the relative expression levels of flaA, flaC, motX, and cheR were determined by qRT-PCR as described in Materials and Methods, with recA mRNA as a reference. Results are averages for three independent cultures. Error bars, standard deviations.

CRP and H-NS act on the same pathway to regulate RpoS expression. In a previous study, we showed that CRP positively modulates the expression of RpoS (49). Since we have shown above that H-NS also enhances the expression of RpoS, we asked if CRP and H-NS act along the same pathway to enhance RpoS. To investigate this question, we constructed the {Delta}hns::Km {Delta}crp double mutant AJB82 and performed epistasis analysis of RpoS-dependent perA expression. We did not observe significant differences between the levels of perA expression in the {Delta}hns::Km, {Delta}crp, and {Delta}crp {Delta}hns::Km mutants (Fig. 8), suggesting that CRP and H-NS act along the same pathway to enhance RpoS expression. Next, we performed qRT-PCR to measure hns mRNA in wild-type and {Delta}crp strains. Strain WL7258{Delta}lacZ ({Delta}crp) was found to produce less hns mRNA than its wild-type precursor (0.49 for the wild type and 0.21 for the {Delta}crp mutant).


Figure 8
View larger version (19K):
[in this window]
[in a new window]

 
FIG. 8. Analysis of perA transcription as a measure of RpoS expression in V. cholerae {Delta}hns and {Delta}crp mutants. Strains C7258{Delta}lacZ, AJB80 (C7258{Delta}lacZ {Delta}hns::Km), WL7258{Delta}lacZ ({Delta}crp), and AJB82 ({Delta}lacZ {Delta}hns::Km {Delta}crp) were grown to stationary phase (16 h) in TSB at 37°C. Total RNA was extracted, and the abundance of perA mRNA was determined by qRT-PCR. Each value is the average for three independent cultures. Error bars, standard deviations.


arrow
DISCUSSION
 
The experiments described above increase our understanding of the complex regulatory interactions that control the expression of HA/protease, a factor proposed to enhance V. cholerae enterotoxicity and the reactogenicity of live vaccine candidates (4, 15, 51). By using HA/protease as an RpoS reporter activity, we show that in contrast to its action in E. coli, H-NS positively affects the expression of RpoS and multiple RpoS-dependent genes in V. cholerae. Recent studies have revealed important differences in the regulation of RpoS expression between E. coli and V. cholerae. For instance, we have shown that expression of RpoS in V. cholerae is positively affected by CRP (49), but the V. cholerae rpoS promoter does not contain the CRP boxes present in the E. coli promoter (see below). Also, V. cholerae mutants lacking relA and polyphosphate kinase (ppk), which are responsible for ppGpp and polyphosphate synthesis, respectively, produced wild-type levels of RpoS and HA/protease (24, 50). Moreover, deletion of Hfq, a factor that enhances rpoS translation in E. coli, did not affect RpoS expression in V. cholerae (10). These results clearly suggest that the regulation of RpoS expression in E. coli and V. cholerae has diverged to promote long-term colonization of different ecological niches. While E. coli is most commonly found in the gastrointestinal tracts of warm-blooded animals, V. cholerae can persist for longer periods in aquatic ecosystems.

Analysis of rpoS-lacZ transcriptional fusions and ectopic expression of rpoS in {Delta}rpoS and {Delta}rpoS {Delta}hns mutants suggested that H-NS acts by a posttranscriptional mechanism. Our data suggest that positive regulation of rpoS expression by H-NS involves rpoS coding sequences cloned into the expression vector pTTRpoS (Fig. 4). In concurrence with the above data, rpoS mRNA was found to decay more rapidly in the {Delta}hns::Km than in the wild-type background (Fig. 5). These findings are in agreement with multiple observations indicating that positive regulation by H-NS is by and large posttranscriptional (1, 12, 26). The reduced abundance of rpoS mRNA in the {Delta}hns mutant suggests that H-NS could bind to rpoS mRNA, as reported for E. coli (6), or act indirectly to enhance rpoS transcript stability. However, our data do not rule out the possibility of H-NS additionally acting at the level of RpoS protein stability. Consistent with the positive effect of H-NS on RpoS expression, our hns mutant was more sensitive than the wild type to high osmolarity (Fig. 6). The surprising resistance of the {Delta}hns mutant to hydrogen peroxide could be explained by elevated expression of other catalase/peroxidase enzymes encoded by V. cholerae. We do not, at the moment, have a clear explanation for the enhanced resistance of the {Delta}hns mutant to a pH of 4.5. Possibly, acidification of LB medium could generate free organic acids to which the {Delta}hns mutant could be more resistant due to elevated expression of ToxR (35). Alternatively, as reported for E. coli (21), H-NS could affect the expression of other amino acid decarboxylases, antiporter systems, or porins that could attenuate the deleterious effect of a low pH.

The {Delta}hns:Km mutant was found to be less motile than the wild type and exhibited reduced expression of flaA, flaC, motX, and cheR-2. In contrast to a previous study using a classical biotype V. cholerae hns mutant (16), we did not observe reduced expression of the regulator flrA in our mutant. Deletion of rpoS negatively affected the expression of flaA, flaC, motX, and cheR-2. This result is in agreement with the finding that RpoS enhances motility in vitro and in vivo to facilitate mucosal escape (42). Analysis of the expression of flaA, flaC, and motX in {Delta}hns, {Delta}rpoS, and {Delta}hns {Delta}rpoS mutants revealed an interesting regulatory pattern. While elimination of rpoS had the strongest negative effect on flaA, flaC, and motX expression, elimination of hns was epistatic to rpoS. This result suggests that in the absence of {sigma}S, H-NS could act as a repressor of these genes. It has been proposed that H-NS can contribute to {sigma}S promoter specificity (20). For instance, initiation of transcription at some RpoS-dependent promoters in the stationary phase by RNAP containing {sigma}S can be more resistant to H-NS repression than transcription by the {sigma}70-containing holoenzyme (20). Transcription of flaA and motX requires {sigma}54 (RpoN), while that of flaC requires a {sigma}28 analog (28, 47). Our studies suggest that transcription of flaA, motX, and flaC by RNAP containing {sigma}54 or {sigma}28 could be repressed by H-NS, while in the stationary phase RpoS could partially override H-NS repression. To further examine this possibility, we used the DNA Curvature Analysis program (http://www.lfd.uci.edu/~gohlke/curve/) to predict the occurrence of curved AT-rich DNA sequences within the 5' noncoding DNA preceding flaA, flaC, and motX. In all cases, we have found regions to which H-NS could potentially bind, with curvature indices similar to or higher than those calculated for the ctxA and toxT promoters, known to be repressed by H-NS (45, 63). Moreover, use of the Virtual Footprint program (http://www.prodoric.de/vfp/) identified high-scoring putative Fis sites within the 5' noncoding sequences preceding flaA, flaC, and motX. Fis sites occur in many promoters repressed by H-NS, in which binding of Fis has been reported to hinder the interaction of H-NS with DNA and to antagonize repression (1, 12). Our results raise the intriguing question of how the different {sigma} factors and H-NS interact to regulate the temporal expression of motility and chemotaxis. Knowledge of the temporal expression of RpoS and H-NS in V. cholerae is required to fully clarify their regulatory input on motility.

In a previous study, we demonstrated that CRP positively affects RpoS expression (49). Use of the Virtual Footprint program did not reveal high-scoring putative CRP binding sites, suggesting that CRP acts indirectly. Therefore, we analyzed whether or not CRP and H-NS act through the same pathway to positively regulate RpoS expression. To this end, we constructed an {Delta}hns {Delta}crp double mutant and performed an epistasis analysis for the expression of RpoS-dependent perA mRNA. Simultaneous deletion of hns and crp did not significantly diminish perA expression more than deletion of hns or crp alone. Since CRP was found by qRT-PCR to positively affect the expression of H-NS, we propose that CRP positively affects RpoS expression in V. cholerae by enhancing H-NS expression (Fig. 9). The positive effect of CRP on H-NS expression is also consistent with the finding that crp mutants are less motile, express reduced flaA and flaC levels (31), and make more CT (31, 53) than the wild type. In fact, CRP can diminish CT expression by parallel mechanisms, which include enhancing H-NS expression, activating quorum sensing (31), and antagonizing the positive regulators AphA and AphB at the tcpPH promoter (29). As for the expression of HA/proteases, our data suggest that CRP impacts hapA transcription by activating quorum sensing (31) and by increasing the expression of H-NS to enhance RpoS biosynthesis.


Figure 9
View larger version (20K):
[in this window]
[in a new window]

 
FIG. 9. Model for the regulatory input of H-NS in virulence, the general stress response, and motility. We propose that CRP acts through H-NS to silence virulence gene expression and enhance RpoS expression. RpoS, in turn, activates genes involved in protease production, stress response, motility, and chemotaxis. For some RpoS-dependent genes (flaA, motX, and flaC), H-NS can also act as a repressor in the absence of an active rpoS gene.

In Fig. 9, we summarize the regulatory interactions between CRP, H-NS, and RpoS that could affect virulence, stress response, motility, and chemotaxis. The genes found to be affected by H-NS in this study can be divided into at least two categories. In class I genes, H-NS appears to affect gene expression by the well-documented mechanism of transcriptional silencing. These genes include ctxA, tcpA (45), katB, and c551. Expression of class II genes is positively affected by H-NS, which acts indirectly by enhancing the expression of RpoS. This class includes the RpoS-dependent genes hapA, cheR-2, flaA, flaC, and motX. Among these genes, flaA, flaC, and motX appear to constitute a subclass in which H-NS could also act as a transcriptional silencer in the absence of rpoS.

The ability of V. cholerae to respond to environmental changes is crucial to both intestinal colonization and survival outside the human host. This adaptation requires the concerted activity of multiple global regulators. A highly complex regulatory network controls the expression of the general stress response, motility, and chemotaxis to enhance V. cholerae environmental fitness. In this study, we provide evidence that H-NS regulates the stress response and motility by RpoS-dependent and -independent mechanisms.


arrow
ACKNOWLEDGMENTS
 
The present study was supported by grant GM008248 from the National Institute of General Medical Sciences to A.J.S and by PHS grant AI63187 from the National Institute of Allergy and Infectious Disease to J.A.B.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, 720 Westview Dr., SW, Atlanta, GA 30310. Phone: (404) 756-6660. Fax: (404) 752-1179. E-mail: asilva-benitez{at}msm.edu Back

{triangledown} Published ahead of print on 12 September 2008. Back

{dagger} Supplemental material for this article may be found at http://jb.asm.org/. Back


arrow
REFERENCES
 
    1
  1. Atlung, T., and H. Ingmer. 1997. H-NS: a modulator of environmentally regulated gene expression. Mol. Microbiol. 24:7-17.[CrossRef][Medline]
  2. 2
  3. Becker, G., E. Klauck, and R. Hengge-Aronis. 1999. Regulation of RpoS proteolysis in Escherichia coli: the response regulator RssB is a recognition factor that interacts with the turnover element in RpoS. Proc. Natl. Acad. Sci. USA 96:6439-6444.[Abstract/Free Full Text]
  4. 3
  5. Benitez, J. A., A. J. Silva, and R. A. Finkelstein. 2001. Environmental signals controlling production of hemagglutinin/protease in Vibrio cholerae. Infect. Immun. 69:6549-6553.[Abstract/Free Full Text]
  6. 4
  7. Benítez, J. A., L. Garcia, A. J. Silva, H. Garcia, R. Fando, B. Cedre, A. Perez, J. Campos, B. L. Rodriguez, J. L. Perez, T. Valmaseda, O. Perez, A. Perez, M. Ramirez, T. Ledon, M. Diaz, M. Lastre, L. Bravo, and G. Sierra. 1999. Preliminary assessment of the safety and immunogenicity of a new CTX{phi}-negative hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate. Infect. Immun. 67:539-545.[Abstract/Free Full Text]
  8. 5
  9. Boin, M. A., M. J. Austin, and C. C. Hase. 2004. Chemotaxis in Vibrio cholerae. FEMS Microbiol. Lett. 239:1-8.[CrossRef][Medline]
  10. 6
  11. Brescia, C. C., M. K. Kaw, and D. D. Sledjeski. 2004. The DNA binding protein H-NS binds to and alters the stability of RNA in vitro and in vivo. J. Mol. Biol. 339:505-514.[CrossRef][Medline]
  12. 7
  13. Brosius, J., A. Ullrich, M. A. Raker, A. Gray, T. J. Dull, R. R. Gutell, and H. F. Noller. 1981. Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli. Plasmid 6:112-118.[CrossRef][Medline]
  14. 8
  15. Chiang, S. L., R. K. Taylor, M. Koomey, and J. J. Mekalanos. 1995. Single amino acid substitutions in the N-terminus of Vibrio cholerae TcpA affect colonization, autoagglutination, and serum resistance. Mol. Microbiol. 17:1133-1142.[CrossRef][Medline]
  16. 9
  17. de Lorenzo, V., L. Eltis, B. Kessler, and K. N. Timmis. 1993. Analysis of the Pseudomonas gene products using lacIq/Ptrp-lac plasmids and transposons that confer conditional phenotypes. Gene 123:17-24.[CrossRef][Medline]
  18. 10
  19. Ding, Y., B. M. Davis, and M. K. Waldor. 2004. Hfq is essential for Vibrio cholerae virulence and down regulates sigma expression. Mol. Microbiol. 53:345-354.[CrossRef][Medline]
  20. 11
  21. Donnenberg, M. S., and J. B. Kaper. 1991. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive selection suicide vector. Infect. Immun. 59:4310-4317.[Abstract/Free Full Text]
  22. 12
  23. Dorman, C. 2004. H-NS: a universal regulator for a dynamic genome. Nat. Rev. Microbiol. 2:391-400.[CrossRef][Medline]
  24. 13
  25. Finkelstein, R. A. 1992. Cholera enterotoxin (choleragen): a historical perspective, p. 155-187. In D. Barua and W. B. Greenough (ed.), Cholera. Plenum Medical Book Company, New York, NY.
  26. 14
  27. Finkelstein, R. A., M. Boesman-Finkelstein, and P. Holt. 1983. Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. Proc. Natl. Acad. Sci. USA 80:1092-1095.[Abstract/Free Full Text]
  28. 15
  29. García, L., M. D. Jidy, H. Garcia, B. L. Rodriguez, R. Fernández, G. Ano, B. Cedre, T. Valmaseda, E. Suzarte, M. Ramirez, Y. Pino, J. Campos, J. Menéndez, R. Valera, D. González, I. González, O. Perez, T. Serrano, M. Lastre, F. Miralles, J. Del Campo, J. L. Maestre, J. L. Perez, A. Talavera, A. Perez, K. Marrero, T. Ledon, and R. Fando. 2005. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers. Infect. Immun. 73:3018-3024.[Abstract/Free Full Text]
  30. 16
  31. Ghosh, A., K. Paul, and R. Chowdhury. 2006. Role of the histone-like nucleoid structuring protein in colonization, motility, and bile-dependent repression of virulence gene expression in Vibrio cholerae. Infect. Immun. 74:3060-3064.[Abstract/Free Full Text]
  32. 17
  33. Gosink, K. K., R. Kobayashi, I. Kawagishi, and C. C. Häse. 2002. Analysis of the role of the three cheA homologs in chemotaxis of Vibrio cholerae. J. Bacteriol. 184:1767-1771.[Abstract/Free Full Text]
  34. 18
  35. Häse, C. C., and R. A. Finkelstein. 1991. Cloning and nucleotide sequence of the Vibrio cholerae hemagglutinin/protease (HA/protease) gene and construction of an HA/protease-negative strain. J. Bacteriol. 173:3311-3317.[Abstract/Free Full Text]
  36. 19
  37. Hengge-Aronis, R. 2002. Signal transduction and regulatory mechanisms involved in control of the {sigma}S (RpoS) subunit of RNA polymerase. Microbiol. Mol. Biol. Rev. 66:373-395.[Abstract/Free Full Text]
  38. 20
  39. Hengge-Aronis, R. 2002. Stationary phase gene regulation: what makes an Escherichia coli promoter {sigma}S-selective? Curr. Opin. Microbiol. 5:591-595.[CrossRef][Medline]
  40. 21
  41. Hommais, F., E. Krin, C. Laurent-Winter, O. Soutourina, A. Malpertuy, J.-P. Le Caer, A. Danchin, and P. Bertin. 2001. Large-scale monitoring of pleiotropic regulation of gene expression by the prokaryotic nucleoid-associated protein, H-NS. Mol. Microbiol. 40:20-36.[CrossRef][Medline]
  42. 22
  43. Hyakutake, A., M. Homma, M. J. Austin, M. A. Boin, C. C. Häse, and I. Kawagishi. 2005. Only one of the five CheY homologs in Vibrio cholerae directly switches flagellar rotation. J. Bacteriol. 187:8403-8410.[Abstract/Free Full Text]
  44. 23
  45. Iwanaga, M., K. Yamamoto, N. Higa, Y. Ichinose, N. Nakasone, and M. Tanabe. 1986. Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor. Microbiol. Immunol. 30:1075-1083.[Medline]
  46. 24
  47. Jahid, I. K., A. J. Silva, and J. A. Benitez. 2006. Polyphosphate stores enhance the ability of Vibrio cholerae to overcome environmental stresses in a low-phosphate environment. Appl. Environ. Microbiol. 72:7043-7049.[Abstract/Free Full Text]
  48. 25
  49. Jobling, M. G., and R. K. Holmes. 1997. Characterization of hapR, a positive regulator of the Vibrio cholerae HA/protease gene hap, and its identification as a functional homologue of the Vibrio harveyi luxR gene. Mol. Microbiol. 26:1023-1034.[CrossRef][Medline]
  50. 26
  51. Johansson, J., B. Dagberg, E. Richet, and B. E. Uhlin. 1998. H-NS and StpA proteins stimulate expression of the maltose regulon in Escherichia coli. J. Bacteriol. 180:6117-6125.[Abstract/Free Full Text]
  52. 27
  53. Kaper, J. B., G. Morris, Jr., and M. M. Levine. 1995. Cholera. Clin. Microbiol. Rev. 8:48-86.[Abstract]
  54. 28
  55. Klose, K. E., and J. J. Mekalanos. 1998. Differential expression of multiple flagellins in Vibrio cholerae. J. Bacteriol. 180:303-316.[Abstract/Free Full Text]
  56. 29
  57. Kovacikova, G., and K. Skorupski. 2001. Overlapping binding sites for the virulence gene regulators AphA, AphB and cAMP-CRP at the Vibrio cholerae tcpPH promoter. Mol. Microbiol. 41:393-407.[CrossRef][Medline]
  58. 30
  59. Krishnan, H. H., A. Ghosh, K. Paul, and R. Chowdhury. 2004. Effect of anaerobiosis on expression of virulence factors in Vibrio cholerae. Infect. Immun. 72:3961-3967.[Abstract/Free Full Text]
  60. 31
  61. Liang, W., A. Pascual-Montano, A. J. Silva, and J. A. Benitez. 2007. The cyclic AMP receptor protein modulates quorum sensing, motility and multiple genes that affect intestinal colonization in Vibrio cholerae. Microbiology 153:2964-2975.[Abstract/Free Full Text]
  62. 32
  63. Majdalani, N., S. Chen, J. Murrow, K. St. John, and S. Gottesman. 2001. Regulation of RpoS by a novel small RNA: the characterization of RprA. Mol. Microbiol. 39:1382-1394.[CrossRef][Medline]
  64. 33
  65. Marcus, H., J. M. Ketley, J. B. Kaper, and R. K. Holmes. 1990. Effect of DNase production, plasmid size, and restriction barriers on transformation of Vibrio cholerae by electroporation and osmotic shock. FEMS Microbiol. Lett. 56:149-154.[Medline]
  66. 34
  67. Mel, S. F., K. J. Fullner, S. Wimer-Mackin, W. L. Lencer, and J. J. Mekalanos. 2000. Association of protease activity in Vibrio cholerae vaccine strains with decrease in transcellular epithelial resistance of polarized T84 intestinal cells. Infect. Immun. 68:6487-6492.[Abstract/Free Full Text]
  68. 35
  69. Merrell, D. S., C. Bailey, J. B. Kaper, and A. Camilli. 2001. The ToxR-mediated organic acid tolerance response of Vibrio cholerae requires OmpU. J. Bacteriol. 183:2746-2754.[Abstract/Free Full Text]
  70. 36
  71. Merrell, D. S., and A. Camilli. 1999. The cadA gene of Vibrio cholerae is induced during infection and plays a role in acid tolerance. Mol. Microbiol. 34:836-849.[CrossRef][Medline]
  72. 37
  73. Merrell, D. S., and A. Camilli. 2002. Acid tolerance of gastrointestinal pathogens. Curr. Opin. Microbiol. 5:51-55.[CrossRef][Medline]
  74. 38
  75. Merrell, D. S., D. L. Hava, and A. Camilli. 2002. Identification of novel factors involved in colonization and acid tolerance of Vibrio cholerae. Mol. Microbiol. 43:1471-1491.[CrossRef][Medline]
  76. 39
  77. Merrell, D. S., A. D. Tischler, S. H. Lee, and A. Camilli. 2000. Vibrio cholerae requires rpoS for efficient intestinal colonization. Infect. Immun. 68:6691-6696.[Abstract/Free Full Text]
  78. 40
  79. Miller, J. H. 1971. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  80. 41
  81. Miller, M. B., K. Skorupski, D. H. Lenz, R. K. Taylor, and B. L. Bassler. 2002. Parallel quorum sensing systems converge to regulate virulence in Vibrio cholerae. Cell 110:303-314.[CrossRef][Medline]
  82. 42
  83. Nielsen, A. T., N. A. Dolganov, G. Otto, M. C. Miller, C. Y. Wu, and G. K. Schoolnik. 2006. RpoS controls the Vibrio cholerae mucosal escape response. PLoS Pathog. 2:e109.[CrossRef][Medline]
  84. 43
  85. Nogueira, T., and M. Springer. 2000. Post-transcriptional control by global regulators of gene expression in bacteria. Curr. Opin. Microbiol. 3:154-158.[CrossRef][Medline]
  86. 44
  87. Nye, M. B., and R. K. Taylor. 2003. Vibrio cholerae H-NS domain structure and function with respect to transcriptional repression of ToxR regulon genes reveals differences among H-NS family members. Mol. Microbiol. 50:427-444.[CrossRef][Medline]
  88. 45
  89. Nye, M. B., J. D. Pfau, K. Skorupski, and R. K. Taylor. 2000. Vibrio cholerae H-NS silences virulence gene expression at multiple steps in the ToxR regulatory cascade. J. Bacteriol. 182:4295-4303.[Abstract/Free Full Text]
  90. 46
  91. Owen-Hughes, T. A., G. D. Pavitt, D. S. Santos, J. M. Sidebotham, C. S. J. Hulton, J. C. D. Hinton, and C. F. Higgins. 1992. The chromatin-associated protein H-NS interacts with curved DNA to influence DNA topology and gene expression. Cell 71:255-265.[CrossRef][Medline]
  92. 47
  93. Prouty, M. G., N. E. Correa, and K. E. Klose. 2001. The novel {sigma}54- and {sigma}28-dependent flagellar gene transcription hierarchy of Vibrio cholerae. Mol. Microbiol. 39:1595-1609.[CrossRef][Medline]
  94. 48
  95. Rothmel, R. D., D. Shinabarger, M. Parsek, T. Aldrich, and A. M. Chakrabarty. 1991. Functional analysis of the Pseudomonas putida regulatory protein CatR: transcriptional studies and determination of the CatR DNA binding site by hydroxyl-radical footprinting. J. Bacteriol. 173:4717-4724.[Abstract/Free Full Text]
  96. 49
  97. Silva, A. J., and J. A. Benitez. 2004. Transcriptional regulation of Vibrio cholerae hemagglutinin/protease by the cyclic AMP receptor protein and RpoS. J. Bacteriol. 186:6374-6382.[Abstract/Free Full Text]
  98. 50
  99. Silva, A. J., and J. A. Benitez. 2006. A Vibrio cholerae relaxed (relA) mutant expresses major virulence factors, exhibits biofilm formation and motility, and colonizes the suckling mouse intestine. J. Bacteriol. 188:794-800.[Abstract/Free Full Text]
  100. 51
  101. Silva, A. J., G. J. Leitch, A. Camilli, and J. A. Benitez. 2006. Contribution of hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera. Infect. Immun. 74:2072-2079.[Abstract/Free Full Text]
  102. 52
  103. Silva, A. J., K. Pham, and J. A. Benitez. 2003. Hemagglutinin/protease expression and mucin gel penetration in El Tor biotype Vibrio cholerae. Microbiology 149:1883-1891.[Abstract/Free Full Text]
  104. 53
  105. Skorupski, K., and R. K. Taylor. 1997. Cyclic AMP and its receptor protein negatively regulate the coordinate expression of cholera toxin and toxin co-regulated pilus in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 94:265-270.[Abstract/Free Full Text]
  106. 54
  107. Spurio, R., M. Falconi, A. Brandi, C. L. Pon, and C. O. Gualerzi. 1997. The oligomeric structure of the nucleoid protein H-NS is necessary for recognition of intrinsically curved DNA and for DNA binding. EMBO J. 16:1795-1805.[CrossRef][Medline]
  108. 55
  109. Starks, M. J. 1987. Multicopy expression vectors carrying the lac repressor for regulated high-level expression of genes in Escherichia coli. Gene 51:255-267.[CrossRef][Medline]
  110. 56
  111. Tendeng, C., C. Badaut, E. Krin, P. Gounon, S. Ngo, A. Danchin, S. Rimsky, and P. Bertin. 2000. Isolation and characterization of vicH, encoding a new pleiotropic regulator in Vibrio cholerae. J. Bacteriol. 182:2026-2032.[Abstract/Free Full Text]
  112. 57
  113. Ueguchi, C., and T. Mizuno. 1993. The Escherichia coli nucleoid protein H-NS functions directly as a transcriptional repressor. EMBO J. 12:1039-1046.[Medline]
  114. 58
  115. Vicente, M., K. F. Chater, and V. De Lorenzo. 1999. Bacterial transcription factors involved in global regulation. Mol. Microbiol. 33:8-17.[CrossRef][Medline]
  116. 59
  117. Wu, Z., D. Milton, P. Nybom, A. Sjö, and K. E. Magnusson. 1996. Vibrio cholerae hemagglutinin/protease (HA/protease) causes morphological changes in cultured epithelial cells and perturbs their paracellular barrier function. Microb. Pathog. 21:111-123.[CrossRef][Medline]
  118. 60
  119. Wu, Z., P. Nybom, and K. E. Magnusson. 2000. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell. Microbiol. 2:11-17.[CrossRef][Medline]
  120. 61
  121. Wu, Z., P. Nybom, T. Sundqvist, and K. E. Magnusson. 1998. Endogenous nitric oxide in MDCK-I cells modulates the Vibrio cholerae haemagglutinin/protease (HA/P)-mediated cytotoxicity. Microb. Pathog. 24:321-326.[CrossRef][Medline]
  122. 62
  123. Yildiz, F. H., and G. K. Schoolnik. 1998. Role of rpoS in stress survival and virulence of Vibrio cholerae. J. Bacteriol. 180:773-784.[Abstract/Free Full Text]
  124. 63
  125. Yu, R. R., and V. J. DiRita. 2002. Regulation of gene expression in Vibrio cholerae by toxT involves both antirepression and RNA polymerase stimulation. Mol. Microbiol. 43:119-134.[CrossRef][Medline]
  126. 64
  127. Zhou, Y., and S. Gottesman. 2006. Modes of regulation of RpoS by H-NS. J. Bacteriol. 188:7022-7025.[Abstract/Free Full Text]


Journal of Bacteriology, November 2008, p. 7335-7345, Vol. 190, No. 22
0021-9193/08/$08.00+0     doi:10.1128/JB.00360-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silva, A. J.
Right arrow Articles by Benitez, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silva, A. J.
Right arrow Articles by Benitez, J. A.